Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of September 20)
Share:
Listens: 0
About
This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.
Eagle's Eye View: Your Weekly CV Update From ACC.org
Miscellaneous
This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.